Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03933969 · ClinicalTrials.gov registry record
Functional Predictive Value of Collective Outcome Measure(s) Status Post Total Hip/Knee Arthroplasty
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 26
- Enrollment target
NCT03933969: Completed study, sponsored by Mayo Clinic.
NCT03933969 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03933969 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Researchers are trying to assess a predictive value or correlation of outcome measures results on subjects following a total knee or total hip arthroplasty in order to better predict the time frame taken to achieve certain functional milestones that are pertinent to subject population.
Primary Outcome
Number of days to weaning from all assistive devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2022-12-23 |
What the finished NCT03933969 record still lists
NCT03933969 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03933969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03933969 about?
NCT03933969 is a clinical study titled "Functional Predictive Value of Collective Outcome Measure(s) Status Post Total Hip/Knee Arthroplasty". Researchers are trying to assess a predictive value or correlation of outcome measures results on subjects following a total knee or total hip arthroplasty in order to better predict the time frame taken to achieve certain functional milestones that are pertinent to subject population.
What is the current status of trial NCT03933969?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2019-06-11. Estimated completion is 2022-12-23.
Who is sponsoring clinical trial NCT03933969?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI